NCT02044549View on ClinicalTrials.gov

Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Postpartum HemorrhageBlood Loss
Interventions
DRUG

carbetocin

Oxycontin analogue

DRUG

Syntometrine

Uterotonins

Trial Locations (1)

12151

Ahmed Maged, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02044549 - Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section | Biotech Hunter | Biotech Hunter